23rd Aug 2007 07:00
Futura Medical PLC23 August 2007 For immediate release 23 August 2007 Futura Medical Plc ("Futura" or "the Company") Appointment of Adviser on Pain Relief Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovativeproducts for the consumer healthcare market, is pleased to announce theappointment of Professor Robert Moore DSc as an advisory consultant to theCompany in the therapeutic area of pain relief. Prof Moore's extensiveexperience of pain relief, from both academic and commercial perspectives, isexpected to be of great value in the development of TPR100, Futura's topicaltreatment for the provision of pain relief. Prof Moore, a former Consultant Biochemist at the Radcliffe Infirmary, Oxford,has published many scientific articles. He moved into industry in 1985 asmanaging director of the UK division of a US diagnostics company, taking it fromsix to 250 employees and achieving profitability. In 1994, he established hisown healthcare consultancy, which has worked for many of the world's leadingpharmaceutical companies, and he has also advised Government. Prof Moore is the founder and Editor-in-Chief of Bandolier, an independentjournal on evidence based healthcare whose electronic version,www.ebandolier.com, receives more than one million visitors each month. In1994, he was appointed Honorary Professor at the Department of Health Sciences,University of Wales. James Barder, Futura's Chief Executive, said: "I am delighted to welcome ascientific adviser of Prof Moore's calibre to Futura. His huge breadth ofexperience, particularly in the area of pain relief, will be of great value inthe development of TPR100, our pipeline product that uses our topicaltrans-dermal delivery technology, DermaSys(R)." For any further information please contact: Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: [email protected] www.futuramedical.co.uk Canaccord Adams Tel: +44 (0) 20 7050 6500Mark Ashurst For any media enquiries please contact:Buchanan Communications Tel: +44 (0) 020 7466 5000Mark Court / Rebecca Dietrich Notes Futura Medical plc Futura Medical is a pharmaceutical group that develops innovative products forconsumer healthcare. The Company is developing a portfolio of products and itsstrategy is to license their manufacture and distribution to majorpharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market ofthe London Stock Exchange. www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Futura Medical